The size of the tissue engineering market was estimated to be USD 12.76 billion in 2021, and it is anticipated to reach USD 31.23 billion by 2030, growing at a CAGR of 10.46% from 2022 to 2030.
The biomedical engineering discipline of tissue engineering integrates cells with engineering, material technologies, and the appropriate biochemical and physicochemical parameters to regenerate, preserve, augment, or replace various types of biological tissues. Tissue engineering (TE), a rapidly growing area, converts fundamental understanding of physics, chemistry, and biology into practical materials, technologies, and therapeutic strategies to repair, replace, or regenerate tissues or organs.
Among the primary goals of the tissue engineering industry in medicine and research include assisting with tissue or organ regeneration, including bone healing (calcified tissue), heart tissue, cartilage tissue, vascular tissue, and pancreatic tissue. Another area of study in this field focuses on the behavior of stem cells. The body's regenerative activities are aided by stem cells, which can develop into various cell types. Tissue engineering's 3D feature makes it possible to examine tumor architecture more thoroughly. It also provides a setting where potential innovative treatments for different illnesses can be tested. It is projected that as knowledge of tissue engineering grows in emerging economies, more R&D activities will aid in the tissue engineering industries' expansion.
- The tissue engineering industry is anticipated to rise as kidney-related illnesses become more common.
Tissue engineering is becoming more popular in various fields, including urological products, orthopedics, burn treatment, and wound and burn care. In the treatment of pediatric patients, tissue engineering can be beneficial. Congenital anomalies such as bladder exstrophy, esophageal atresia, and congenital diaphragmatic hernia provide significant surgical complications due to the absence of tissues or organs at birth.
Additionally, the care of burn wounds has seen a considerable increase in interest in tissue engineering methods. Increased burn and trauma-related injuries are anticipated to fuel the growth of the global tissue engineering industry in the coming years. Tissue-engineered skin replacements have significant promise for widespread applications in wound healing, particularly to address the limited availability of autologous skin.
- The desire for more effective medical treatments and the rise in chronic diseases are driving the need for qualified tissue engineering researchers, which is anticipated to propel market expansion throughout the projected period.
There is a demand for more efficient medical treatments due to the aging population and the increase in chronic diseases. Due to this, there is a need for qualified tissue engineering researchers to develop these technologies. This is one of the key factors anticipated to fuel the market's expansion.
Using mechanical devices to restore damaged tissues and surgical reconstruction are alternatives provided by tissue engineering.
However, there are numerous issues with tissue engineering
Current tissue engineering techniques have several drawbacks, including ineffective cell growth, unstable and insufficient growth factor production that hinders cell communication and proper response, and a lack of appropriate biomaterials and techniques to record appropriate physiological architectures.
Another limitation of tissue engineering is the inability to control cellular processes and their many properties (biological, electrochemical, mechanical, and others), as well as problems with biosensors and biomolecular detection. Additionally, despite the growing interest in tissue engineering research, the expensive treatment cost limits the growth of the tissue engineering industry.
Impact of COVID-19
The availability of materials in the tissue engineering sector is just one of the difficulties brought on by the COVID-19 pandemic. Several laboratory supplies and product shipments have been canceled, and in nearly every case, the delivery of the materials has been delayed or postponed. This made it difficult for corporations and research labs that rely on research to choose alternate options, and as a result, it has recently impacted research output.